- Home
- PIM vs LENZ Comparison
PIM vs LENZ Comparison
Compare PIM & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PIM | LENZ |
|---|---|---|
| Founded | 1988 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 155.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PIM | LENZ |
|---|---|---|
| Price | $3.16 | $4.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 41.0K | ★ 694.5K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 8.28% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $63.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.07 | $4.54 |
| 52 Week High | $3.50 | $50.19 |
Technical Indicators
Market Signals| Indicator | PIM | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 44.84 |
| Support Level | $3.13 | $4.67 |
| Resistance Level | $3.21 | $6.18 |
| Average True Range (ATR) | 0.03 | 0.33 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 40.00 | 27.44 |
Price Performance
Historical ComparisonAbout PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.